Literature DB >> 25110294

Global vaccine supply. The increasing role of manufacturers from middle income countries.

Donald P Francis1, Yu-Ping Du2, Alexander R Precioso3.   

Abstract

Hallmarks in the remarkable evolution of vaccines and their application include the eradication of smallpox, the development and delivery of the early childhood vaccines and the emergence of recombinant vaccines initiated by the hepatitis B vaccine. Now we enter a most exciting era as vaccines are increasingly produced and delivered in less developed countries. The results are dramatic decreases in childhood morbidity and mortality around the world.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Less develop countries; Production; Supply; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 25110294     DOI: 10.1016/j.vaccine.2014.07.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  1 in total

Review 1.  Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.

Authors:  Amy Grenham; Tonya Villafana
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.